United States · Markets & Finance · Quartz
GE HealthCare is buying radiopharmaceutical maker Sofie Biosciences for $945 million
The deal expands GE HealthCare's pharmaceutical diagnostics footprint and adds a late-stage cancer imaging tracer to its pipeline
Read the full article on Quartz Sign in to saveMediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (qz.com)




